Market Overview:
The global in vitro fertilization (IVF) test market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing demand for assisted reproductive technologies (ART) and rising prevalence of infertility. In addition, the increasing number of single-parent families and growing awareness about IVF are also contributing to the growth of the market. The embryo biopsy segment is expected to grow at a CAGR of 8.0% from 2018 to 2030, owing to the increasing demand for preimplantation genetic testing (PGT). PGT helps in detecting chromosomal abnormalities and genetic disorders in embryos before implantation into the uterus, which helps in improving pregnancy rates and reducing miscarriage rates. The KIR-HLAC genotyping segment is projected to grow at a CAGR of 9.1% during the forecast period, owingto its abilityto identify risk factors for diseases such as cancerand autoimmune diseases.
Product Definition:
In vitro fertilization (IVF) is a process of assisted reproduction in which eggs are removed from a woman's ovaries and fertilized by sperm outside the body. The resulting embryo is then transferred to the woman's uterus to implant and grow.
Embryo Biopsy:
Embryo biopsy is the removal of a part of the embryo for microscopic analysis. It is used in IVF (In Vitro fertilization) to check if there are any abnormal cells in the embryo that may cause chromosomal abnormalities in future. Chromosomal aberrations can be either inherited by subsequent generations or can occur as a result of environmental factors such as radiation, chemicals or lifestyle choices.
Preimplantation Genetic Testing for Aneuploidy:
The global preimplantation genetic testing for aneuploidy (PGT-A) market size was valued at USD 1.5 billion in 2017 and is expected to register a CAGR of XX% over the forecast period. Increasing prevalence of aneuploidies, rising demand for IVF treatment, and technological advancements are some major factors driving the growth of this market globally.
Application Insights:
The global in vitro fertilization test market is segmented based on application as a hospital, IVF research center and others. The hospital segment dominated the market in 2017 due to rising number of infertility cases globally. According to the Centers for Disease Control and Prevention (CDC), around 1,223,200 American women aged between 15-44 years were diagnosed with infertile conditions in 2015. Moreover, an estimated 664,000 American men were diagnosed with infertility problems that same year. This rise in prevalence is expected to contribute towards growth of this segment over the forecast period.
The IVF research center application segment is anticipated to witness significant growth during the forecast period owing to increasing R&D activities pertaining related procedures worldwide coupled with growing adoption of assisted reproductive technology by highly capable patients who are 35 years old or more.
Regional Analysis:
Europe dominated the global market in 2017. The presence of well-established healthcare infrastructure, government funding for infertility treatment, and high prevalence of infertility are some factors responsible for its large share. In addition, the European Society of Human Reproduction and Embryology (ESHRE) has released guidelines to regulate IVF procedures based on different stages of development which is further anticipated to boost revenue growth during the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to a rise in awareness about IVF treatments among people as well as increasing government initiatives towards infertile women’s health care services.
Growth Factors:
- Increasing awareness about in vitro fertilization and its benefits is driving the growth of the In Vitro Fertilization Test market.
- Rising number of infertility cases is also propelling the demand for In Vitro Fertilization Test products and services, thereby fueling the growth of this market.
- Technological advancements in In Vitro Fertilization Test procedures are providing new opportunities for players operating in this market.
- Growing demand for assisted reproductive technologies (ART) is contributing to the expansion of the In Vitro Fertilization Test market globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
In Vitro Fertilization Test Market Research Report
By Type
Embryo Biopsy, Preimplantation Genetic Testing for Aneuploidy, KIR-HLAC Genotyping, Others
By Application
Hospital, IVF Research Center, Others
By Companies
CooperSurgical, Inc., Vitrolife AB, Igenomix, Natera, iGLS, CiceroDx, Esco Micro Pte Ltd., Texas Fertility Center
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
219
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global In Vitro Fertilization Test Market Report Segments:
The global In Vitro Fertilization Test market is segmented on the basis of:
Types
Embryo Biopsy, Preimplantation Genetic Testing for Aneuploidy, KIR-HLAC Genotyping, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, IVF Research Center, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CooperSurgical, Inc.
- Vitrolife AB
- Igenomix
- Natera
- iGLS
- CiceroDx
- Esco Micro Pte Ltd.
- Texas Fertility Center
Highlights of The In Vitro Fertilization Test Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Embryo Biopsy
- Preimplantation Genetic Testing for Aneuploidy
- KIR-HLAC Genotyping
- Others
- By Application:
- Hospital
- IVF Research Center
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the In Vitro Fertilization Test Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
In vitro fertilization (IVF) is a process of assisted reproductive technology in which eggs are retrieved from a woman, and sperm are collected from a man. The eggs and sperm are then combined in a laboratory setting to create embryos. If successful, these embryos will be transferred back into the woman’s uterus for implantation.
Some of the major players in the in vitro fertilization test market are CooperSurgical, Inc., Vitrolife AB, Igenomix, Natera, iGLS, CiceroDx, Esco Micro Pte Ltd., Texas Fertility Center.
The in vitro fertilization test market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 In Vitro Fertilization Test Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 In Vitro Fertilization Test Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 In Vitro Fertilization Test Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the In Vitro Fertilization Test Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global In Vitro Fertilization Test Market Size & Forecast, 2020-2028 4.5.1 In Vitro Fertilization Test Market Size and Y-o-Y Growth 4.5.2 In Vitro Fertilization Test Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Embryo Biopsy
5.2.2 Preimplantation Genetic Testing for Aneuploidy
5.2.3 KIR-HLAC Genotyping
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 IVF Research Center
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global In Vitro Fertilization Test Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 In Vitro Fertilization Test Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Embryo Biopsy
9.6.2 Preimplantation Genetic Testing for Aneuploidy
9.6.3 KIR-HLAC Genotyping
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 IVF Research Center
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Embryo Biopsy
10.6.2 Preimplantation Genetic Testing for Aneuploidy
10.6.3 KIR-HLAC Genotyping
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 IVF Research Center
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Embryo Biopsy
11.6.2 Preimplantation Genetic Testing for Aneuploidy
11.6.3 KIR-HLAC Genotyping
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 IVF Research Center
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Embryo Biopsy
12.6.2 Preimplantation Genetic Testing for Aneuploidy
12.6.3 KIR-HLAC Genotyping
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 IVF Research Center
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Embryo Biopsy
13.6.2 Preimplantation Genetic Testing for Aneuploidy
13.6.3 KIR-HLAC Genotyping
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 IVF Research Center
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 In Vitro Fertilization Test Market: Competitive Dashboard
14.2 Global In Vitro Fertilization Test Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 CooperSurgical, Inc.
14.3.2 Vitrolife AB
14.3.3 Igenomix
14.3.4 Natera
14.3.5 iGLS
14.3.6 CiceroDx
14.3.7 Esco Micro Pte Ltd.
14.3.8 Texas Fertility Center